Drug Discovery · Biotechnology
Quotient Sciences: Risk & public record
Quotient Sciences: 80 research papers in five years.
Data updated Nov 22, 2026 · Back to the company report
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Public record
Quotient Sciences: 80 research papers in five years.
Research outputpapers its people wrote, per OpenAlex
80papers in five years
1.8kcitations
Pharmaceutical studies and practices
Medicine
63 papers
Pharmacogenetics and Drug Metabolism
Pharmacology, Toxicology and Pharmaceutics
56 papers
Drug Solubulity and Delivery Systems
Pharmacology, Toxicology and Pharmaceutics
38 papers
Advanced Drug Delivery Systems
Pharmacology, Toxicology and Pharmaceutics
23 papers
Statistical Methods in Clinical Trials
Mathematics
17 papers
Works most with: AstraZeneca (United Kingdom), F. Hoffmann-La Roche AG, Novo Nordisk (Denmark), Novo Nordisk Foundation, Novo Holdings (Denmark), Sanofi (France)
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
